相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。New Delhi Metallo-Beta-Lactamase Facilitates the Emergence of Cefiderocol Resistance in Enterobacter cloacae
Dennis Nurjadi et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2022)
Rapid Development of Cefiderocol Resistance in Carbapenem-resistant Enterobacter cloacae During Therapy Is Associated With Heterogeneous Mutations in the Catecholate Siderophore Receptor cirA
Sabrina Klein et al.
CLINICAL INFECTIOUS DISEASES (2022)
Efficacy and safety of cefiderocol or best available therapy for the treatment of serious infections caused by carbapenem-resistant Gram-negative bacteria (CREDIBLE-CR): a randomised, open-label, multicentre, pathogen-focused, descriptive, phase 3 trial
Matteo Bassetti et al.
LANCET INFECTIOUS DISEASES (2021)
In Vitro Evolution of Cefiderocol Resistance in an NDM-Producing Klebsiella pneumoniae Due to Functional Loss of CirA
Christi L. McElheny et al.
MICROBIOLOGY SPECTRUM (2021)
Contribution of PER-Type and NDM-Type β-Lactamases to Cefiderocol Resistance in Acinetobacter baumannii
Laurent Poirel et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2021)
Cefiderocol: A Review in Serious Gram-Negative Bacterial Infections
Yahiya Y. Syed
DRUGS (2021)
A genomic surveillance framework and genotyping tool for Klebsiella pneumoniae and its related species complex
Margaret M. C. Lam et al.
NATURE COMMUNICATIONS (2021)
The Lancet Infectious Diseases Commission on antimicrobial resistance: 6 years later
Ramanan Laxminarayan et al.
LANCET INFECTIOUS DISEASES (2020)
Structural Basis of Reduced Susceptibility to Ceftazidime-Avibactam and Cefiderocol in Enterobacter cloacae Due to AmpC R2 Loop Deletion
Akito Kawai et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2020)
Clinical Evolution of AmpC-Mediated Ceftazidime-Avibactam and Cefiderocol Resistance in Enterobacter cloacae Complex Following Exposure to Cefepime
Ryan K. Shields et al.
CLINICAL INFECTIOUS DISEASES (2020)
Cefiderocol: A Siderophore Cephalosporin
Rania M. El-Lababidi et al.
ANNALS OF PHARMACOTHERAPY (2020)
Cefiderocol: A Novel Siderophore Cephalosporin against Multidrug-Resistant Gram-Negative Pathogens
Jacinda C. Abdul-Mutakabbir et al.
PHARMACOTHERAPY (2020)
Reduced susceptibility mechanism to cefiderocol, a siderophore cephalosporin, among clinical isolates from a global surveillance programme (SIDERO-WT-2014)
Naoki Kohira et al.
JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE (2020)
NDM Metallo-β-Lactamases and Their Bacterial Producers in Health Care Settings
Wenjing Wu et al.
CLINICAL MICROBIOLOGY REVIEWS (2019)
Cefiderocol: A Siderophore Cephalosporin with Activity Against Carbapenem-Resistant and Multidrug-Resistant Gram-Negative Bacilli
George G. Zhanel et al.
DRUGS (2019)
Epidemiology and mortality in bacterial bloodstream infections in patients with hematologic malignancies
Duygu Mert et al.
JOURNAL OF INFECTION IN DEVELOPING COUNTRIES (2019)
In Vitro Activity of Cefiderocol Against a Broad Range of Clinically Important Gram-negative Bacteria
Yoshinori Yamano
CLINICAL INFECTIOUS DISEASES (2019)
In vitro activity of cefiderocol, a siderophore cephalosporin, against a recent collection of clinically relevant carbapenem-non-susceptible Gram-negative bacilli, including serine carbapenemase- and metallo-β-lactamase-producing isolates (SIDERO-WT-2014 Study)
Krystyna M. Kazmierczak et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2019)
Treatment of Infections Caused by Extended-Spectrum-Beta-Lactamase-, AmpC-, and Carbapenemase-Producing Enterobacteriaceae
Jesus Rodriguez-Bano et al.
CLINICAL MICROBIOLOGY REVIEWS (2018)
Ceftazidime-Avibactam: A Review in the Treatment of Serious Gram-Negative Bacterial Infections
Matt Shirley
DRUGS (2018)
CRISPR-Cas9 and CRISPR-Assisted Cytidine Deaminase Enable Precise and Efficient Genome Editing in Klebsiella pneumoniae
Yu Wang et al.
APPLIED AND ENVIRONMENTAL MICROBIOLOGY (2018)
In Vitro Antibacterial Properties of Cefiderocol, a Novel Siderophore Cephalosporin, against Gram-Negative Bacteria
Akinobu Ito et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
In Vitro Activity of the Siderophore Cephalosporin, Cefiderocol, against Carbapenem-Nonsusceptible and Multidrug-Resistant Isolates of Gram-Negative Bacilli Collected Worldwide in 2014 to 2016
Meredith A. Hackel et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
The global epidemiology of carbapenemase-producing Enterobacteriaceae
David van Duin et al.
VIRULENCE (2017)
Bloodstream infections caused by Klebsiella pneumoniae in onco-hematological patients: clinical impact of carbapenem resistance in a multicentre prospective survey
Enrico Maria Trecarichi et al.
AMERICAN JOURNAL OF HEMATOLOGY (2016)
TonB or not TonB: is that the question?
Karla D. Krewulak et al.
BIOCHEMISTRY AND CELL BIOLOGY (2011)
TonB-dependent energy transduction between outer and cytoplasmic membranes
Kathleen Postle et al.
BIOMETALS (2007)
Structure of colicin I receptor bound to the R-domain of colicin Ia: implications for protein import
Susan K. Buchanan et al.
EMBO JOURNAL (2007)
Quantification of known components of the Escherichia coli TonB energy transduction system:: TonB, ExbB, ExbD and FepA
PI Higgs et al.
MOLECULAR MICROBIOLOGY (2002)
分享论文
